Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial

Cancer Treat Rep. 1986 Apr;70(4):533-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Carcinoma, Squamous Cell / drug therapy*
  • Drug Evaluation
  • Esophageal Neoplasms / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mitoguazone / adverse effects
  • Mitoguazone / therapeutic use*
  • Pancreatic Neoplasms / drug therapy*
  • Stomach Neoplasms / drug therapy*

Substances

  • Mitoguazone